Researchers at the University of Bristol have identified a specific biological mechanism by which GLP-1 drugs, the same class ...

A common class of drugs called anticholinergics might boost risks for heart failure and other dangerous cardiac conditions, a new study says. People taking the largest amounts of anticholinergic drugs ...

New research shows that cardiovascular protection from GLP-1 receptor agonists such as semaglutide and tirzepatide diminishes within months of discontinuation.

Weight-loss drugs may prevent deadly heart complications by opening blocked blood vessels after heart attacks, groundbreaking new research reveals.

Commonly prescribed heart medications, including statins and diuretics, do not negatively affect the survival of patients with multiple myeloma. SHARJAH, EMIRATE OF ...